EMCURE · Emcure Pharmaceuticals Limited · Financials
Market Cap
448.04B INR
Shares
189.71M
Volume · Nov 13
294.54K
Avg daily vol (3M)
203.12K
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Income-statement, balance-sheet and cash-flow figures read from the company's own published financial reports.
Revenue
92.04B
+16.6%
FY2026
Net Income
9.24B
+35.7%
FY2026
Operating Cash Flow
9.44B
+10.8%
FY2026
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | TTM | FY2026 | FY2025 |
|---|---|---|---|
| INR | 102.34B | 92.04B | 78.96B |
| INR | 4.3B | 4.15B | 3.84B |
| INR | 1.51B | 1.44B | 1.76B |
| INR | 14.94B | 12.87B | 9.71B |
| INR | 4.02B | 3.46B | 2.64B |
| INR | 10.93B | 9.24B | 6.81B |
Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest.
Capital Returned to Shareholders
Cash spent on share repurchases and dividends per fiscal year, as reported on the cash-flow statement. Across FY2025–FY2026: 568.53M in dividends.
Debt Profile
No verified debt profile is available yet. This does not establish that the company has no debt or covenants.